Waga, S., Hannon, G.J., Beach, D. and Stillman, B. The p21 inhibitor of cyclin-dependent kinases Controls DNA replication by interaction with PCNA fsee commentsj. Naturę 1994; 369: 574-578.
Wagner, A.J., Kokontis, J.M. and Hay, N. Myc-mediated apoptosis reąuires wild-type p53 in a manner independent of celi cycle arrest and the ability of p53 to induce p21 wafl/cipl. Genes Dev 1994; 8: 2817-2830.
Wahl, A.F., Donaldson, K.L., Fairchild, C., Lee, F.Y., Foster, S.A., Demers, G.W. and Galloway, D.A. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 1996; 2: 72-79.
Wang, C.Y., Cusack, J.C., Jr., Liu, R. and Baldwin, A.S., Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999a; 5: 412-417.
Wang, C.Y., Guttridge, D.C., Mayo, M.W. and Baldwin, A.S., Jr. NF-kappaB induces expression of the Bcl-2 homologue Al/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Celi Biol 1999b; 19: 5923-5929.
Wang, C.Y., Mayo, M.W. and Baldwin, A.S., Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996a; 274: 784-787.
Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V. and Baldwin, A.S., Jr. NF-kappaB antiapoptosis: induction of TRAFI and TRAF2 and c-IAPl and C-IAP2 to suppress caspase-8 activation. Science 1998; 281: 1680-1683.
Wang, X.W., Forrester, K., Yeh, H., Feitelson, M.A., Gu, J.R. and Harris, C.C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91: 2230-2234.
Wang, X.W., Vermeulen, W., Courscn, J.D., Gibson, M., Lupold, S.E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J.H. and Harris, C.C. The XPB and XPD
DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 1996b; 10: 1219-1232.
Wang, X.W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.M., Wang, Z., Freidberg, E.C., Evans, M.K., Taffe, B.G. and et al. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 1995; 10: 188-195.
Wang, X.W., Zhan, Q., Coursen, J.D., Khan, M.A., Kontny, H.U., Yu, L., Hollander, M.C., 0'Connor, P.M., Fornace, A.J., Jr. and Harris, C.C. GADD45 induction of a G2/M celi cycle checkpoint. Proc Natl Acad Sci USA 1999c; 96: 3706-3711.
Wang, Y. and Prives, C. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Naturę 1995; 376: 88-91.
Waterman, M.J., Stavridi, E.S., Waterman, J.L. and Halazonetis, T.D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet 1998; 19: 175-178.
Webster, G.A. and Perkins, N.D. Transcriptional cross talk between NF-kappaB and p53. Mol Celi Biol 1999; 19: 3485-3495.
Webster, K., Parish, J., Pandya, M., Stern, P.L., Ciarkę, A.R. and Gaston, K. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem 2000; 275: 87-94.
Werness, B.A., Levine, A.J. and Howlcy, P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-79.
Winters, Z.E., Ongkeko, W.M., Harris, A.L. and Norbury, C.J. p53 regulates Cdc2 independently of inhibitory phosphoiylation to reinforce radiation-induced G2 arrest in human cells. Oncogene 1998; 17: 673-684.
187